CNR1 and Hepatic steatosis: Furthermore, another CB1 antagonist, rimonabant, attenuated hepatic steatosis through repression of hepatomegaly, reduced hepatic TNF‐α levels, and increased plasma adiponectin levels in an obese Zucker fa/fa rat model.17